Successful treatment with a rituximab-based regimen of a splenic marginal zone lymphoma with villous lymphocytes in a very frail patient on maintenance dialysis.
Niscola
Pasquale
P
Palumbo
Roberto
R
Scaramucci
Laura
L
Tendas
Andrea
A
Cupelli
Luca
L
Giovannini
Marco
M
Piccioni
Daniela
D
Dentamaro
Teresa
T
Perrotti
Alessio Pio
AP
de Fabritiis
Paolo
P
D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008214:Lymphocytes / Q000187:drug effects*; D018442:Lymphoma, B-Cell, Marginal Zone / Q000150:complications / Q000188:drug therapy*; D006435:Renal Dialysis; D000069283:Rituximab; D013160:Splenic Neoplasms / Q000150:complications / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab